Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population

Journal of Child Neurology

Volumn 23, Issue 8, 2008, Pages 883-888

  Ouyang, Lijing ^a,b   Grosse, Scott D ^a   Kenneson, Aileen ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NONE   (United States)

Author keywords

Cost; Duchenne; Medical care; Muscular dystrophy; Neuromuscular disease

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RESPIRATORY TRACT INFECTION; SCREENING; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; DRUG COSTS; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; MALE; MUSCULAR DYSTROPHIES; PATIENT ADMISSION; UNITED STATES; UTILIZATION REVIEW;

EID: 48449094545     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808314962     Document Type: Article

References (9)

1. Emery AE The muscular dystrophies. Lancet. 2002;359:687-695.
2. Papazian O., Alfonso I. Adolescents with muscular dystrophies. Adolesc Med. 2002;13:511-535.
3. Kenneson A., Kolor K., Yang Q., et al. Trends and racial disparities in muscular dystrophy deaths in the United States, 1983-1998: An analysis of multiple cause mortality data. Am J Med Genet A. 2006;140:2289-2297.
4. Bushby K., Straub V. Nonmolecular treatment for muscular dystrophies. Curr Opin Neurol. 2005;18:511-518.
5. MarketScan® Database. Ann Arbor, MI: The Medstat Group Inc; 2003-2004.
6. Newacheck PW, Kim SE A national profile of health care utilization and expenditures for children with special health care needs. Arch Pediatr Adolesc Med. 2005;159:10-17.
7. Ireys HT, Anderson GF, Shaffer TJ, Neff JM Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. Pediatrics. 1997;100:197-204.
8. Moxley RT 3rd, Ashwal S., Pandya S., et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2005;64(1):13-20.
9. Bushby K., Bourke J., Bullock R., et al. The multidisciplinary management of Duchenne muscular dystrophy. Curr Pediatrics. 2005;15:292-300.